Aperio Group’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $8.14M | Buy |
102,580
+4,100
| +4% | +$297K | 0.02% | 634 |
|
|
2020
Q3 | $6.1M | Sell |
98,480
-184
| -0.2% | -$12K | 0.02% | 666 |
|
|
2020
Q2 | $6.51M | Buy |
98,664
+18,256
| +23% | +$1.09M | 0.02% | 623 |
|
|
2020
Q1 | $3.81M | Buy |
80,408
+19,376
| +32% | +$969K | 0.02% | 763 |
|
|
2019
Q4 | $3.35M | Buy |
61,032
+816
| +1% | +$42.8K | 0.01% | 880 |
|
|
2019
Q3 | $2.95M | Sell |
60,216
-6,336
| -10% | -$318K | 0.01% | 897 |
|
|
2019
Q2 | $3.47M | Buy |
66,552
+1,084
| +2% | +$54.6K | 0.01% | 848 |
|
|
2019
Q1 | $3.25M | Sell |
65,468
-12,016
| -16% | -$541K | 0.01% | 847 |
|
|
2018
Q4 | $2.8M | Sell |
77,484
-65,196
| -46% | -$2.72M | 0.01% | 851 |
|
|
2018
Q3 | $7.28M | Sell |
142,680
-1,752
| -1% | -$77.6K | 0.03% | 554 |
|
|
2018
Q2 | $5.34M | Buy |
144,432
+3,736
| +3% | +$143K | 0.03% | 637 |
|
|
2018
Q1 | $5.31M | Buy |
140,696
+15,536
| +12% | +$549K | 0.03% | 627 |
|
|
2017
Q4 | $4.05M | Buy |
125,160
+4,852
| +4% | +$154K | 0.02% | 707 |
|
|
2017
Q3 | $3.64M | Buy |
120,308
+9,276
| +8% | +$275K | 0.02% | 716 |
|
|
2017
Q2 | $3.26M | Sell |
111,032
-4,648
| -4% | -$127K | 0.02% | 731 |
|
|
2017
Q1 | $2.94M | Sell |
115,680
-2,316
| -2% | -$59.8K | 0.02% | 739 |
|
|
2016
Q4 | $3.03M | Sell |
117,996
-68,332
| -37% | -$1.8M | 0.02% | 679 |
|
|
2016
Q3 | $5.1M | Buy |
186,328
+129,556
| +228% | +$3.56M | 0.04% | 528 |
|
|
2016
Q2 | $1.6M | Buy |
56,772
+22,732
| +67% | +$584K | 0.01% | 898 |
|
|
2016
Q1 | $804K | Sell |
34,040
-1,592
| -4% | -$35.1K | 0.01% | 1143 |
|
|
2015
Q4 | $802K | Sell |
35,632
-3,012
| -8% | -$68.7K | 0.01% | 1109 |
|
|
2015
Q3 | $893K | Sell |
38,644
-88
| -0.2% | -$2.21K | 0.01% | 1021 |
|
|
2015
Q2 | $953K | Buy |
38,732
+628
| +2% | +$15.7K | 0.01% | 992 |
|
|
2015
Q1 | $955K | Sell |
38,104
-1,944
| -5% | -$46.2K | 0.01% | 955 |
|
|
2014
Q4 | $925K | Sell |
40,048
-2,188
| -5% | -$50.1K | 0.01% | 940 |
|
|
2014
Q3 | $988K | Buy |
42,236
+4,824
| +13% | +$113K | 0.01% | 866 |
|
|
2014
Q2 | $866K | Buy |
37,412
+2,988
| +9% | +$66K | 0.01% | 898 |
|
|
2014
Q1 | $735K | Buy |
+34,424
| New | +$775K | 0.01% | 1154 |
|
|
2013
Q4 | – | Sell |
-31,776
| Closed | -$689K | – | 1049 |
|
|
2013
Q3 | $636K | Buy |
31,776
+18,760
| +144% | +$356K | 0.01% | 1045 |
|
|
2013
Q2 | $225K | Buy |
+13,016
| New | +$216K | 0.01% | 1432 |
|
Other funds holding TECH
BCM
OCBV
JSP
DDC
Aperio Group's TECH Position: Q4 2020 in Review
Aperio Group increased its Bio-Techne (TECH) stake by 4.2% in Q4 2020, buying an estimated $297K and bringing the position to 102,580 shares worth $8.14M. The position accounts for 0.02% of the portfolio, ranked #634.
Aperio Group first reported a position in TECH in Q2 2013 and has held it in 30 quarters since. 441 funds tracked by Wall St. Rank hold TECH as of Q4 2020.
- Aperio Group held 102,580 shares of Bio-Techne worth $8.14M as of Q4 2020.
- Aperio Group bought 4,100 Bio-Techne shares in Q4 2020, an estimated $297K.
- Bio-Techne made up 0.02% of Aperio Group's portfolio in Q4 2020, its #634 holding.
- Aperio Group first reported a position in Bio-Techne in Q2 2013 and has held it in 30 quarters since.
- 441 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.